EU picks antibody treatments, arthritis drug as preferred COVID-19 therapies – Reuters

EU picks antibody treatments, arthritis drug as preferred COVID-19 therapies – Reuters

The European Commission on Tuesday picked four antibody treatments and a repurposed rheumatoid arthritis drug
by Eli Lilly (LLY.N) for an initial portfolio of preferred drugs to treat COVID-19.

Read More…

You May Also Like